Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Kwon

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
JCO Oncology Practice|June 24, 2025
Veterans' Decision Making for Prostate Cancer Germline Testing After Informed Consent With Their Oncologist: A Mixed-Methods StudyDaniel H Kwon, Maren T Scheuner, Marissa McPhaul, et al.
JCO Oncology Practice|December 21, 2021
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate CancerDaniel H Kwon, Sneha Karthikeyan, Alison Chang, et al.
Cancer Medicine|November 21, 2024
Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate CancerDaniel H Kwon, Lauren Trihy, Nika Darvish, et al.
Cancer|March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancerDaniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Urologic Oncology|November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracersDaniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
JNCI Cancer Spectrum|June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Open Forum Infectious Diseases|February 24, 2022
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) StudyGowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
JCO Oncology Practice|June 24, 2025
Veterans' Decision Making for Prostate Cancer Germline Testing After Informed Consent With Their Oncologist: A Mixed-Methods StudyDaniel H Kwon, Maren T Scheuner, Marissa McPhaul, et al.
JCO Oncology Practice|December 21, 2021
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate CancerDaniel H Kwon, Sneha Karthikeyan, Alison Chang, et al.
Cancer Medicine|November 21, 2024
Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate CancerDaniel H Kwon, Lauren Trihy, Nika Darvish, et al.
Cancer|March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancerDaniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Urologic Oncology|November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracersDaniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
JNCI Cancer Spectrum|June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Open Forum Infectious Diseases|February 24, 2022
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) StudyGowri Satyanarayana, Kyle T Enriquez, Tianyi Sun, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Pageof 4